These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 16208141)

  • 1. Hypertension, antihypertensives and mutations in the Von Hippel-Lindau gene in renal cell carcinoma: results from the Netherlands Cohort Study.
    Schouten LJ; van Dijk BA; Oosterwijk E; Hulsbergen-van de Kaa CA; Kiemeney LA; Goldbohm RA; Schalken JA; van den Brandt PA
    J Hypertens; 2005 Nov; 23(11):1997-2004. PubMed ID: 16208141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol consumption and mutations or promoter hypermethylation of the von Hippel-Lindau gene in renal cell carcinoma.
    Schouten LJ; van Dijk BA; Oosterwijk E; van Engeland M; Hulsbergen-van de Kaa CA; Kiemeney LA; Goldbohm RA; Kester A; de Vogel S; Schalken JA; van den Brandt PA
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3543-50. PubMed ID: 19064569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index and von Hippel-Lindau gene mutations in clear-cell renal cancer: Results of the Netherlands Cohort Study on diet and cancer.
    Smits KM; Schouten LJ; Hudak E; Verhage B; van Dijk BA; Hulsbergen-van de Kaa CA; Goldbohm RA; Oosterwijk E; van den Brandt PA
    Ann Epidemiol; 2010 May; 20(5):401-4. PubMed ID: 20382342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study.
    van Houwelingen KP; van Dijk BA; Hulsbergen-van de Kaa CA; Schouten LJ; Gorissen HJ; Schalken JA; van den Brandt PA; Oosterwijk E
    BMC Cancer; 2005 Jun; 5():57. PubMed ID: 15932632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carotenoid and vitamin intake, von Hippel-Lindau gene mutations and sporadic renal cell carcinoma.
    van Dijk BA; Schouten LJ; Oosterwijk E; Hulsbergen-van de Kaa CA; Kiemeney LA; Goldbohm RA; Schalken JA; van den Brandt PA
    Cancer Causes Control; 2008 Mar; 19(2):125-34. PubMed ID: 17992578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique molecular alteration patterns in von Hippel-Lindau (VHL) gene in a cohort of sporadic renal cell carcinoma patients from Pakistan.
    Khaliq S; Ajaz S; Firasat S; Shahid S; Hasan AS; Sultan G; Mohsin R; Hashmi A; Mubarak M; Naqvi SA; Rizvi SA; Mehdi SQ; Abid A
    Mutat Res; 2014; 763-764():45-52. PubMed ID: 24727139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma.
    Brauch H; Weirich G; Hornauer MA; Störkel S; Wöhl T; Brüning T
    J Natl Cancer Inst; 1999 May; 91(10):854-61. PubMed ID: 10340905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic mutations of the von Hippel-Lindau disease gene in renal carcinomas occurring in patients with long-term dialysis.
    Inoue H; Nonomura N; Kojima Y; Shiba M; Oka D; Arai Y; Nakayama M; Takayama H; Nishimura K; Mori H; Okuyama A
    Nephrol Dial Transplant; 2007 Jul; 22(7):2052-5. PubMed ID: 17438007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity.
    Trotta AM; Santagata S; Zanotta S; D'Alterio C; Napolitano M; Rea G; Camerlingo R; Esposito F; Lamantia E; Anniciello A; Botti G; Longo N; Botti G; Pignata S; Perdonà S; Scala S
    J Exp Clin Cancer Res; 2018 Dec; 37(1):297. PubMed ID: 30514329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline polymorphisms in the Von Hippel-Lindau and Hypoxia-inducible factor 1-alpha genes, gene-environment and gene-gene interactions and renal cell cancer.
    van de Pol JAA; van den Brandt PA; van Engeland M; Godschalk RWL; van Schooten FJ; Hogervorst JGF; Schouten LJ
    Sci Rep; 2020 Jan; 10(1):137. PubMed ID: 31924838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cigarette smoking, von Hippel-Lindau gene mutations and sporadic renal cell carcinoma.
    van Dijk BA; Schouten LJ; Oosterwijk E; Hulsbergen-van de Kaa CA; Kiemeney LA; Goldbohm RA; Schalken JA; van den Brandt PA
    Br J Cancer; 2006 Aug; 95(3):374-7. PubMed ID: 16892044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and epigenetic alterations in the von hippel-lindau gene: the influence on renal cancer prognosis.
    Smits KM; Schouten LJ; van Dijk BA; Hulsbergen-van de Kaa CA; Wouters KA; Oosterwijk E; van Engeland M; van den Brandt PA
    Clin Cancer Res; 2008 Feb; 14(3):782-7. PubMed ID: 18245539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma.
    Perier A; Fregni G; Wittnebel S; Gad S; Allard M; Gervois N; Escudier B; Azzarone B; Caignard A
    Oncogene; 2011 Jun; 30(23):2622-32. PubMed ID: 21258414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
    Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM
    J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequencing of the von Hippel-Lindau gene in canine renal carcinoma.
    Pressler BM; Williams LE; Ramos-Vara JA; Anderson KI
    J Vet Intern Med; 2009; 23(3):592-7. PubMed ID: 19422471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and predictive value of VHL gene alteration in renal cell carcinoma: a meta-analysis and review.
    Kim BJ; Kim JH; Kim HS; Zang DY
    Oncotarget; 2017 Feb; 8(8):13979-13985. PubMed ID: 28103578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of E2F1 by the von Hippel-Lindau tumour suppressor protein predicts survival in renal cell cancer patients.
    Mans DA; Vermaat JS; Weijts BG; van Rooijen E; van Reeuwijk J; Boldt K; Daenen LG; van der Groep P; Rowland BD; Jans JJ; Roepman R; Voest EE; van Diest PJ; Verhaar MC; de Bruin A; Giles RH
    J Pathol; 2013 Sep; 231(1):117-29. PubMed ID: 23744542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VHL protein alterations in sporadic renal cell carcinoma.
    Giménez-Bachs JM; Salinas-Sánchez AS; Sánchez-Sánchez F; Lorenzo-Romero JG; Donate-Moreno MJ; Pastor-Navarro H; Carrión-López P; Escribano-Martínez J; Virseda-Rodríguez JA
    Clin Oncol (R Coll Radiol); 2007 Dec; 19(10):784-9. PubMed ID: 17919893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth kinetics in von Hippel-Lindau-associated renal cell carcinoma.
    Jilg CA; Neumann HP; Gläsker S; Schäfer O; Ardelt PU; Schwardt M; Schultze-Seemann W
    Urol Int; 2012; 88(1):71-8. PubMed ID: 22156657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].
    Gong K; Zhang N; Na X; Wu G; Yang XY; Xin DQ; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):390-3. PubMed ID: 15854350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.